IRIS UniCatt

Montuschi, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.901
EU - Europa 2.553
AS - Asia 1.315
SA - Sud America 289
AF - Africa 20
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.097
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.854
DE - Germania 575
SE - Svezia 554
CN - Cina 479
SG - Singapore 459
IT - Italia 345
UA - Ucraina 264
BR - Brasile 248
IE - Irlanda 176
FR - Francia 119
GB - Regno Unito 110
PL - Polonia 104
ID - Indonesia 102
FI - Finlandia 84
TR - Turchia 63
RU - Federazione Russa 62
IN - India 53
HK - Hong Kong 36
CA - Canada 33
BE - Belgio 32
NL - Olanda 27
AT - Austria 26
KR - Corea 20
VN - Vietnam 20
IR - Iran 14
AR - Argentina 13
AU - Australia 12
CH - Svizzera 12
JP - Giappone 12
BD - Bangladesh 11
EC - Ecuador 11
ES - Italia 11
ZA - Sudafrica 8
IL - Israele 7
LT - Lituania 7
MX - Messico 7
BG - Bulgaria 6
CO - Colombia 6
CZ - Repubblica Ceca 6
EG - Egitto 6
PT - Portogallo 5
EU - Europa 4
IQ - Iraq 4
PK - Pakistan 4
RS - Serbia 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
KG - Kirghizistan 3
LU - Lussemburgo 3
NP - Nepal 3
PA - Panama 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
IM - Isola di Man 2
IS - Islanda 2
KZ - Kazakistan 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
YE - Yemen 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GA - Gabon 1
JO - Giordania 1
KE - Kenya 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PY - Paraguay 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.097
Salva come PNG Salva come JPEG
Città #
Chandler 491
Ashburn 276
Singapore 241
Dublin 172
San Mateo 147
Jacksonville 120
Cattolica 114
Nanjing 110
Ann Arbor 101
Jakarta 100
Warsaw 100
Bremen 87
Wilmington 84
Woodbridge 74
New York 72
Boston 70
Fairfield 59
Lawrence 55
Redwood City 55
Munich 52
Moscow 51
Izmir 46
Dearborn 43
Seattle 41
The Dalles 40
Houston 38
Rome 38
Beijing 37
Milan 37
Los Angeles 36
Princeton 33
Brussels 29
Frankfurt am Main 28
Boardman 27
Hangzhou 26
Hong Kong 24
Shanghai 23
Guangzhou 21
Nanchang 21
Nürnberg 20
Vienna 20
Marseille 19
Cambridge 18
Mountain View 18
Norwalk 18
São Paulo 18
Chicago 17
Columbus 17
Redmond 17
Hefei 15
Shenyang 15
Fremont 14
Hebei 14
Helsinki 14
Seoul 13
Tianjin 12
Falls Church 11
Jiaxing 11
London 11
Zhengzhou 11
Changsha 10
Düsseldorf 10
Toronto 10
University Park 10
Detroit 9
Lancaster 9
Montreal 9
Pune 9
Santa Clara 9
Changchun 8
Nuremberg 8
Paris 8
Rio de Janeiro 8
Amsterdam 7
Edinburgh 7
Kunming 7
Roubaix 7
San Francisco 7
Augusta 6
Bergamo 6
Buffalo 6
Campo Grande 6
Contagem 6
Dhaka 6
Istanbul 6
Kish 6
Lappeenranta 6
Leawood 6
Ottawa 6
Philadelphia 6
Southend 6
Washington 6
Ypsilanti 6
Belo Horizonte 5
Bogotá 5
Busto Arsizio 5
Cairo 5
Fortaleza 5
Guayaquil 5
Hanoi 5
Totale 3.819
Salva come PNG Salva come JPEG
Nome #
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 266
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 181
Development of a sensing array for human breath analysis based on SWCNT layers functionalized with semiconductor organic molecules 162
Detection and characterization of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients 148
Computed tomography for evaluation of the small airway disease in asthma. 141
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 138
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 137
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 137
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 129
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD 124
Inhaled muscarinic acethylcholine receptor antagonists for treatment of COPD 122
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 119
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 119
Impact of air pollution on respiratory diseases in urban areas: a systematic review 119
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 118
Investigational prostaglandin D2 receptor antagonists for airway inflammation 112
Development of a Sensing Array for Human Breath Analysis Based on SWCNT Layers Functionalized with Semiconductor Organic Molecules 109
Dupilumab for the treatment of asthma 106
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics 103
NMR spectroscopy-based metabolomics of exhaled breath condensate in inflammatory respiratory diseases 102
Exhaled Nitric Oxide Measurement in Patients Affected by Nasal Polyposis 99
Exploring the performance of a functionalized CNT-based sensor array for breathomics through clustering and classification algorithms: From gas sensing of selective biomarkers to discrimination of chronic obstructive pulmonary disease 95
Indirect monitoring of lung inflammation 92
Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children 91
Pharmacotherapy of asthma: regular treatment or on demand? 87
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 87
Stratification of asthma phenotypes by airway proteomic signatures 84
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 83
Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends 82
Novel perspectives in the detection of oral and nasal oxidative stress and inflammation in pediatric united airway diseases 81
NMR-Based Metabolomics for the Assessment of Inhaled Pharmacotherapy in Chronic Obstructive Pulmonary Disease Patients 80
8-isoprostane in exhaled breath condensate after experimental exposure to wood smoke in humans 78
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 77
Dupilumab for the treatment of asthma 76
The combined impact of exhaled nitric oxide and sputum eosinophils monitoring in asthma treatment: a prospective cohort study 75
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort 75
Impulse oscillometry and nitrogen washout test in the assessment of small airway dysfunction in asthma: correlation with quantitative computed tomography 75
Severe asthma: One disease and multiple definitions 75
Comparison of classification methods in breath analysis by electronic nose 74
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 74
LC/MS/MS analysis of leukotriene B4 in exhaled breath condensate for assessing lung inflammation. 73
Role of beta-blockers in patients with COPD: current perspective 73
Leukotriene modifiers for asthma treatment 71
WHITIN-DAY AND BETWEEN-DAY REPEATIBILITY OF MEASURERMENTS WITH AN ELECTRONIC NOSE IN PATIENTS WITH COPD 70
8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. 69
Immediate allergic reactions to beta-lactams: diagnosis and therapy. 68
Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues 66
The electronic nose in respiratory medicine. 65
Exhaled breath condensate in COPD: application in clinical practice 64
Drugs for chronic obstructive pulmonary disease. 63
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 63
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD 62
Triple inhaled therapy for chronic obstructive pulmonary disease 62
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 62
Separating Smoking-Related Diseases Using NMR-Based Metabolomics of Exhaled Breath Condensate 60
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease 60
Comparison of two exhaled biomarkers in children with and without sleep disordered breathing 58
Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects 58
New perspectives in pharmacological treatment of mild persistent asthma 56
Treatable traits in the European U-BIOPRED adult asthma cohorts 56
Predictive markers of bronchial hyperreactivity in a large cohort of young adults With cough variant asthma 56
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis 55
Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping 55
Exhaled nitric oxide as a biomarker in COPD and related comorbidities 55
Metabolomic analysis by nuclear magnetic resonance spectroscopy as a new approach to understanding inflammation and monitoring of pharmacological therapy in children and young adults with cystic fibrosis 55
Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma 55
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. 54
Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. 53
Non-invasive biomarkers of lung inflammation in smoking subjects 50
Exhaled breath condensate, nasal eosinophil cationic protein level and nasal cytology during immunotherapy for cypress allergy. 50
Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma 50
Exhaled volatile organic compounds as markers for medication use in asthma 48
Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects 47
High sputum total adiponectin is associated with low odds for asthma. 47
Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project 47
IL-17-high asthma with features of a psoriasis immunophenotype 47
Characteristics and treatment regimens across ERS SHARP severe asthma registries 46
Vilanterol trifenatate for the treatment of COPD 44
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux 42
Exhaled breath condensate biomarkers of airway inflammation and oxidative stress in COPD 41
Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis. 41
Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis 40
Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids 39
Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study 38
Role of beta-blockers in patients with COPD: current perspective 38
Medication Adherence in Patients With Severe Asthma Prescribed Oral Corticosteroids in the U-BIOPRED Cohort 35
Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers 35
Editorial: Insights in respiratory pharmacology: 2021 34
Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis 32
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study 32
eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy 32
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 31
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation 27
Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome 26
A European Respiratory Society technical standard: exhaled biomarkers in lung disease 25
Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort 21
Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status 21
Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease 21
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation 16
Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma 16
Totale 7.208
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 0 0 0 0 0 0 0 0 0 0 94
2020/2021677 31 81 21 78 84 24 57 16 102 49 117 17
2021/2022868 57 64 22 68 66 35 22 138 39 46 173 138
2022/20231.633 201 215 131 277 133 226 48 125 186 17 45 29
2023/2024815 34 248 17 113 26 104 56 10 7 39 64 97
2024/20251.430 32 50 124 54 121 39 57 54 237 159 352 151
Totale 7.241